Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Caribou Biosciences (CRBU) Interest Expenses (2020 - 2021)

Caribou Biosciences (CRBU) has disclosed Interest Expenses for 2 consecutive years, with $2000.0 as the latest value for Q2 2021.

  • Quarterly Interest Expenses fell 60.0% to $2000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Mar 2022, down 88.24% year-over-year, with the annual reading at $8000.0 for FY2021, 60.0% down from the prior year.
  • Interest Expenses for Q2 2021 was $2000.0 at Caribou Biosciences, down from $6000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $6000.0 in Q3 2020, with the low at $2000.0 in Q2 2021.